Tibial Plateau Fractures: Treatment with Injectable Calcium Phosphate Cement

Abstract

Rates of secondary reduction loss in tibial plateau fractures ranged from 7% to 33% following treatment with calcium phosphate cement, and the percentage of patients with very good or good Lysholm scores ranged Irons 57% to 81%. Two small retrospective cohort studies suggest that use of calcium phosphate cement leads to decreased operative time compared with buttress plating and bone grafting. Whether loss of reduction is less common with calcium phosphate cement versus bone graft is unclear. Additional methodologically rigorous comparative studies with larger populations are necessary to establish the safety and efficacy of SRS and to establish the superiority of SRS over bone grafting.